CTLA4 and cancer: The immune system can be harnessed to detect and destroy cancer cells through inhibition of immune checkpoints, such as cytotoxic T-lymphocyte associated protein 4 (CTLA-4) and programmed cell death 1 or its ligand (PD-1 and PD-L1) [1].